GV 2017 GP, L.P.'s Net Worth
$228 Million
Who is GV 2017 GP, L.P.?
GV 2017 GP, L.P. has an estimated net worth of $228 Million. This is based on reported shares across multiple companies, which include Arcus Biosciences, Inc., Verve Therapeutics, Inc., Decibel Therapeutics, Inc., and Gitlab Inc..
SEC CIK
GV 2017 GP, L.P.'s CIK is 0001733339
Past Insider Trading and Trends
2021 was GV 2017 GP, L.P.'s most active year for acquiring shares with 3 total transactions. GV 2017 GP, L.P.'s most active month to acquire stocks was the month of January. 2022 was GV 2017 GP, L.P.'s most active year for disposing of shares, totalling 37 transactions. GV 2017 GP, L.P.'s most active month to dispose stocks was the month of October. 2021 saw GV 2017 GP, L.P. paying a total of $0.00 for 15,704,330 shares, this is the most they've acquired in one year. In 2022 GV 2017 GP, L.P. cashed out on 637,388 shares for a total of $14,837,299.65, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Arcus Biosciences, Inc. (RCUS) Snapshot price: $15.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.92M |
—
|
—
| 1.92M |
Mar 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Gitlab Inc. (GTLB) Snapshot price: $72.835
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Verve Therapeutics, Inc. (VERV) Snapshot price: $10.99
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.39% | -145.75K |
$31.14 | -$3,025,610.98 | 10.37M |
Scheduled
|
Nov 4
| ||
Form 4
| -2.19% | -234.66K |
$34.23 | -$5,310,657.90 | 10.47M |
Scheduled
|
Nov 2 - Nov 3
| ||
Form 4
| -2.36% | -256.98K |
$37.79 | -$6,501,030.76 | 10.62M |
Scheduled
|
Oct 31 - Nov 1
| ||
Form 4
|
∞
| 6.32M |
—
|
—
| 6.32M |
Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Decibel Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 494.65K |
—
|
—
| 494.65K |
Feb 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |